Titanium-45 (45Ti) Radiochemistry and Applications in Molecular Imaging
Molecular imaging is an important part of modern medicine which enables the non-invasive identification and characterization of diseases. With the advancement of radiochemistry and scanner technology, nuclear medicine is providing insight into efficient treatment options for individual patients. Titanium-45 (45Ti) is a lesser-explored radionuclide that is garnering increasing interest for the development of positron emission tomography (PET) radiopharmaceuticals. This review discusses aspects of this radionuclide including production, purification, radiochemistry development, and molecular imaging studies.
- Research Organization:
- University of Alabama, Birmingham, AL (United States)
- Sponsoring Organization:
- USDOE; USDOE Office of Science (SC)
- Grant/Contract Number:
- SC0021269
- OSTI ID:
- 2335830
- Journal Information:
- Pharmaceuticals, Journal Name: Pharmaceuticals Journal Issue: 4 Vol. 17; ISSN 1424-8247; ISSN PHARH2
- Publisher:
- MDPI AGCopyright Statement
- Country of Publication:
- Switzerland
- Language:
- English
Similar Records
Tomographic radiopharmaceutical imaging
Radiopharmaceuticals for diagnosis. [Final] report, 1 January 1991--31 December 1993
PRODUCTION CONSIDERATIONS FOR THE CLASSICAL PET NUCLIDES.
Journal Article
·
1988
· Proc. IEEE; (United States)
·
OSTI ID:6037803
Radiopharmaceuticals for diagnosis. [Final] report, 1 January 1991--31 December 1993
Technical Report
·
1993
·
OSTI ID:10107772
PRODUCTION CONSIDERATIONS FOR THE CLASSICAL PET NUCLIDES.
Book
·
2001
·
OSTI ID:784251